Tech Company Financing Transactions
Ascletis Funding Round
On 9/30/2015, Ascletis raised $35 million in funding from Pavilion Capital Partners and private investors.
Transaction Overview
Company Name
Announced On
9/30/2015
Transaction Type
Venture Equity
Amount
$35,000,100
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1785 Jianghai Rd. Gemini Internatinal Bldg. No.4 Binjiang Di 1801
Hangzhou, 310000
China
Hangzhou, 310000
China
Phone
Website
Email Address
Overview
Ascletis focuses on building a global specialty therapeutics business dedicated to discovering and developing important new treatments for cancer and infectious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jinzi Wu
Chief Financial Officer
Lindi Tan
VP - Operations
Judy Wu
VP - Regulatory Affairs
Vivian Chen
VP - Sales
Helen Yan
Browse more venture capital transactions:
Prev: 9/30/2015: PingMD venture capital transaction
Next: 9/30/2015: Swarm64 venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs